Early empiric antibiotic therapy for febrile neutropenia patients at low risk

Infectious Disease Clinics of North America

Volumn 10, Issue 2, 1996, Pages 223-237

  Rolston, K V I ^a   Rubenstein, E B ^a   Freifeld, A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; GROWTH FACTOR; MEZLOCILLIN; OFLOXACIN;

ADULT; ANTIBIOTIC THERAPY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER PATIENT; CAREGIVER; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEVER; HOME CARE; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; INFECTION; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; MORBIDITY; MORTALITY; NEOPLASM; NEUTROPENIA; NEUTROPHIL; ORAL DRUG ADMINISTRATION; OUTPATIENT; REVIEW; RISK; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0029884724     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70297-X     Document Type: Article

References (29)

1. American Society of Clinical Oncology Ad Hoc Colony Stimulating Factor Guideline Expert Panel Recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines J Clin Oncol 12 1994 2471 2508
2. R.O. Bash J.A. Katz J.V. Cash Safety and cost-effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia Cancer 74 1994 189 196
3. G.P. Bodey Overview of the problem of infections in the immunocompromised host Am J Med 79 suppl 1985 56 61
4. G.P. Bodey M. Buckley Y.S. Sathe Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia Ann Intern Med 64 1996 328 339
5. G.P. Bodey V. Fainstein L.S. Elting β-Lactam regimens for the febrile neutropenic patient Cancer 65 1990 9 16
6. B.E. DePauw S.C. Dereskinski R. Feld Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer: A multicenter randomized trial Ann Intern Med 120 1994 834 844
7. A. Freifeld P. Pizzo Colony-stimulating factors and neutropenia: Intersection of data and clinical relevance J Nat Cancer Inst 87 1995 781 782
8. M. Gardembas-Pain B. Desablens L. Sensebe Home treatment of febrile neutropenia: An empirical oral antibiotic regimen Ann Oncol 2 1991 485 487
9. C. Gilbert B. Meisenberg J. Vredenburgh Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support J Clin Oncol 12 1994 1005 1011
10. J.A. Glaspy G. Bleecker J. Crawford The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy Eur J Cancer 29A suppl 7 1993 S23 S30
11. W.T. Hughes D. Armstrong G.P. Bodey Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever J Infect Dis 161 1990 381 396
12. P.G. Jones K.V.I. Rolston V. Fainstein Aztreonam therapy in neutropenic patients with cancer Am J Med 81 1986 243 248
13. R.C. Lau S.M. King S.E. Richardson Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics Pediatr Hematol Oncol 11 1994 417 421
14. D.W. Maher G.J. Lieschke M. Green Filgrastim in patients with chemotherapy-induced febrile neutropenia Ann Intern Med 121 1994 492 501
15. I.A. Malik Z. Abbas M. Karim Randomized comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patients Lancet 339 1992 1092 1096
16. I.A. Malik W.A. Khan A. Aziz Self-administered antibiotic therapy for chemotherapy-induced low-risk febrile neutropenia in patients with non-hematologic neoplasms Clin Infect Dis 19 1994 522 527
17. I.A. Malik W.A. Khan M. Karim Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trial Am J Med 98 1995 224 231
18. J.I. Mayordomo F. Rivera M.T. Diaz-Puente Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors J Natl Cancer Inst 87 1995 803 808
19. S.E. McLinn M. Moskal J. Goldfarb Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children Antimicrob Agents Chemother 38 1994 315 318
20. P.A. Pizzo J.W. Hathorn J. Hiemenz A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia N Engl J Med 315 1986 552 558
21. P.A. Pizzo K.J. Robichaud R. Wesley Fever in the pediatric and young adult patient with cancer: A prospective study of 1001 episodes Medicine 61 1982 153 165
22. Rolston KVI, Rubenstein EB, Elting L, et al: Ambulatory management of febrile episodes in low-risk neutropenic patients [abstract 2235]. In Programs and Abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy, San Francisco, 1995, p 333
23. K. Rolston E. Rubenstein S. Frisbee-Hume Outpatient treatment of febrile episodes in low-risk neutropenic cancer patients [abstract 1505] Proceedings of the American Society Clinical Oncology, Orlando 12 1993 436
24. E.B. Rubenstein K. Rolston Outpatient management of febrile episodes in neutropenic cancer patients Support Care Cancer 2 1994 369 373
25. E.B. Rubenstein K. Rolston R.S. Benjamin Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer Cancer 71 1993 3640 3646
26. M. Rubin J.W. Hathorn P.A. Pizzo Controversies in the management of febrile neutropenic cancer patients Cancer Invest 6 1988 167 184
27. J.A. Talcott R. Finberg R.J. Mayer The medical course of cancer patients with fever and neutropenia Arch Intern Med 148 1988 2561 2568
28. J.A. Talcott R.D. Siegel R. Finberg Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule J Clin Oncol 10 1992 316 322
29. J.A. Talcott A. Whalen J. Clark Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: A pilot study of 30 patients based on a validated prediction rule J Clin Oncol 12 1994 107 114